Thermo Fisher Scientific Adds Digital PCR to Genetic Analysis Capabilities

Applied Biosystems QuantStudio Absolute Q Digital PCR System*, the first integrated digital PCR solution, is ideal for oncology, cell and gene therapy development and other research applications WALTHAM, Mass., Sept. 20, 2021 /PRNewswire/ — Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, today launched the Applied Biosystems QuantStudio Absolute Q Digital PCR... Read more

Brooks Automation Announces Agreement To Sell Its Semiconductor Solutions Group Business To Thomas H. Lee Partners

Brooks Automation Announces Agreement To Sell Its Semiconductor Solutions Group Business To Thomas H. Lee Partners CHELMSFORD, Mass., Sept. 20, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today announced that it has entered into a definitive agreement to sell its Semiconductor Solutions Group business (or “automation business”) to Thomas H. Lee Partners, L.P. (“THL”) for... Read more

PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend

WALTHAM, Mass.–(BUSINESS WIRE)–Sep. 17, 2021– PerkinElmer, Inc. (NYSE: PKI) a global leader committed to innovating for a healthier world, today announced it has completed its acquisition of BioLegend, a leading, worldwide provider of life science antibodies and reagents for a total consideration of approximately $5.25 billion. The acquisition, the largest in PerkinElmer’s history, further expands the... Read more

Roche receives positive CHMP opinion for Gavreto® (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer

Gavreto showed robust and durable clinical responses in people with NSCLC with RET fusions If approved, Gavreto will be the first and only targeted treatment approved by the EMA that includes first-line treatment of people with RET fusion-positive advanced NSCLC Basel, 17 September 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the... Read more

Automated Enzyme Analyzers Streamline Enzyme Assay Applications

The Thermo Scientific Gallery Enzyme Master analyzers enable efficient, reliable enzyme analysis workflows from method development to routine analysis SUNNYVALE, Calif., Sept. 16, 2021 /PRNewswire/ — Multi-enzyme analysis can now be achieved through a single, fully-automated enzyme analyzer, benefitting industrial enzyme manufacturers and enzyme users in the food, beverage, biopharmaceutical, fuel ethanol and chemical, and solid... Read more

Queen Anne and the Mystery of the Blue Pigment

It all started with a painting of Queen Anne. After many years spent in storage, this anonymous oil canvas was recently cleaned and restored by Jenny Williamson, painting conservator at the Glynn Vivian Art Gallery (GVAG) in Swansea, UK. The portrait could not be dated correctly and the painter was unknown. There are no dates... Read more

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda’s Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations Oncomine Dx Target Test now approved as CDx for five targeted NSCLC therapies in the U.S. CARLSBAD, Calif., Sept. 15, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher... Read more

BioLife Solutions Announces CFO Retirement

Roderick de Greef Concludes 20 Year Association with BioLife BOTHELL, Wash., Sept. 15, 2021 /PRNewswire/ — BioLife Solutions, Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that Roderick de Greef, Chief Financial Officer, plans to retire on December 31,... Read more

Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle

Sep 15, 2021 Diverse investments from Israel, Mexico, Poland, South Africa, United Kingdom and United States SAN DIEGO, Sept. 15, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) has selected seven new genomics companies to join the third global funding cycle of Illumina Accelerator. The global company creation engine, focused on partnering with entrepreneurs to build breakthrough genomics startups,... Read more